Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia
- 31 October 1999
- Vol. 54 (4) , 670-678
- https://doi.org/10.1016/s0090-4295(99)00209-5
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- LONGITUDINAL PROSTATE GROWTH RATES DURING 5 YEARS IN RANDOMLY SELECTED COMMUNITY MEN 40 TO 79 YEARS OLDJournal of Urology, 1999
- THE IMPACT OF MEDICAL THERAPY ON BOTHER DUE TO SYMPTOMS, QUALITY OF LIFE AND GLOBAL OUTCOME, AND FACTORS PREDICTING RESPONSEJournal of Urology, 1998
- Combined analysis of two multicenter studies of finasteride 5 mg in the treatment of symptomatic benign prostatic hyperplasiaProstate Cancer and Prostatic Diseases, 1997
- Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care studyClinical Therapeutics, 1997
- Testing to Predict Outcome After Transurethral Resection of the ProstateJournal of Urology, 1997
- The International Continence Society “Benign Prostatic Hyperplasia” Study: The Bothersomeness of Urinary SymptomsJournal of Urology, 1997
- Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hyperplasiaThe Prostate, 1996
- Linking clinical variables with health-related quality of life. A conceptual model of patient outcomesJAMA, 1995
- A New Patient Weighted Symptom Score System (DAN-PSS-1)Scandinavian Journal of Urology and Nephrology, 1993
- Validation of a new quality of life questionnaire for benign prostatic hyperplasiaJournal of Clinical Epidemiology, 1992